HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
Southlake, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:HSCS; HSCSW) (“HeartSciences” or the “Company”), would like to remind its shareholders to vote ahead of its upcoming 2023 Annual Meeting of Stockholders (“Annual Meeting”) on Wednesday, January 17, 2024 at 9:00 a.m. Eastern (8:00 a.m. Central) Time. All shareholders on record of our outstanding shares of common stock and preferred stock at the close of business on November 20, 2023, are entitled to participate and vote at the Annual Meeting.
Related news for (HSCS)
- HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
- Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
- HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
- HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
- HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 – Featuring CEO Andrew Simpson